D. Anderson & Company Supports the American College of Rheumatology
D. Anderson & Company (DAC) will be a corporate sponsor of the American College of Rheumatology Research and Education Foundation. Established in 1985, the ACR Research and Education Foundation is the second-largest funding source for rheumatology research and training in the United States and aims to advance research and training to improve the health of people with rheumatic diseases.
"Having evolved from a niche contract research organization serving the rheumatology sector, DAC has been a longtime advocate of rheumatology education, research and practice support," said DAC President and CEO Diana Anderson, Ph.D. "We are proud to augment the work of the foundation and have made this our corporate cause for 2010."
Dr. Anderson is currently serving a second term on the ACR Research and Education Foundation Development Advisory Council, which is charged with providing oversight and leadership in raising philanthropic support. She is also a member of the Circle of Leadership-distinguished donors who contribute to the foundation's Annual Giving Campaign. Dr. Anderson is leveraging her industry influence to raise awareness and financial support of the foundation as it strives toward reaching a goal of $31 million over the next year.
Most notably, DAC is providing pro bono logistics and public relations services for the Dallas launch of the Within Our Reach campaign, the foundation's first and only disease-targeted research initiative. Since its launch in 2006, Within Our Reach has awarded 45 grants totaling $18 million toward innovative research focused on finding a cure for rheumatoid arthritis. The Dallas launch will get under way February 12 with an exclusive cocktail reception at the Rosewood Mansion on Turtle Creek in Dallas. Guests will include rheumatology doctors, patients and others seeking a cure for rheumatic diseases. Special guests include Stanley B. Cohen, M.D., president of the American College of Rheumatology.
"We are honored to have the support of Dr. Anderson and her team at D. Anderson & Company," Dr. Cohen said. "We have a long and storied history with DAC, given Dr. Anderson's leadership in the ACR Research and Education Foundation, and it seems a natural progression to partner with them on such an important project."
Driving Diversity with the Integrated Research Model
October 16th 2024Ashley Moultrie, CCRP, senior director, DEI & community engagement, Javara discusses current trends and challenges with achieving greater diversity in clinical trials, how integrated research organizations are bringing care directly to patients, and more.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
The Rise of Predictive Engagement Tools in Clinical Trials
November 22nd 2024Patient attrition can be a significant barrier to the success of a randomized controlled trial (RCT). Today, with the help of AI-powered predictive engagement tools, clinical study managers are finding ways to proactively reduce attrition rates in RCTs, and increase the effectiveness of their trial. In this guide, we look at the role AI-powered patient engagement tools play in clinical research, from the problems they’re being used to solve to the areas and indications in which they’re being deployed.
